Publication | Closed Access
An exploratory retrospective multicenter study of prognostic factors in mCRPC patients undergoing enzalutamide treatment: Focus on early PSA decline and kinetics at time of progression
24
Citations
22
References
2019
Year
Our study has demonstrated that PSA dynamics after ENZ administration may be a useful prognostic factor for mCRPC patients.
| Year | Citations | |
|---|---|---|
Page 1
Page 1